Terpenoid ID | TKC112576 | |
Chirality | TKC104069 | |
Cell line | 0 | |
Protein target | 35 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 90 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC112576 | HCT-116 | HCT-116; HCT.116; HCT_116; HCT116; HCT116wt; CoCL2 | 4.0 | % | Survival | C4910 | |
TKC112576 | HT-29 | HT 29; HT29 | 22.0 | % | Survival | C4349 | |
TKC112576 | Vero | VERO; VeroCCL81; Vero 81; Vero-81; Verda reno | 50.0 | nM | IC50 | ||
TKC112576 | DLD-1 | DLD 1; DLD1; CoCL3 | 30.0 | nM | IC50 | C4349 | |
TKC112576 | HepG2 | 89.0 | nM | Potency | C3728 | Orphanet_449 | |
TKC112576 | HEK293 | 46.0 | nM | Potency | |||
TKC112576 | SH-SY5Y | SH-Sy5y; SHSY5Y; SHSY-5Y; SK-SH-SY5Y; SY5Y; SH-SY5Y Parental | 316.0 | nM | Potency | C3270 | Orphanet_635 |
TKC112576 | SN12C | SN-12C | 10.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC112576 | MDA-N | MDAN | 20.0 | nM | GI50 | C3802 | |
TKC112576 | ACHN | 10.0 | nM | GI50 | C6975 | Orphanet_319298 | |
TKC112576 | NCI-H23 | NCI.H23; NCI H23; H-23; H23; NCIH23 | 11.0 | nM | GI50 | C3512 | |
TKC112576 | UO-31 | UO.31; UO31; U031 | 12.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC112576 | HL-60 | HL 60; HL.60 HL60; Human Leukemia-60 | 10.0 | nM | GI50 | C9154 | Orphanet_519 |
TKC112576 | HOP-92 | HOP 92; HOP.92; HOP92; Hop92; Hopkins-92 | 22.0 | nM | GI50 | C2926 | |
TKC112576 | SF-539 | SF-539; SF-539 BT; SF.539; SF 539 | 13.0 | nM | GI50 | C3796 | Orphanet_251576 |
TKC112576 | DU-145 | DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 | 12.0 | nM | GI50 | C4863 | |
TKC112576 | Malme-3M | MALME-3M; MALME 3M; Malme-3 M; MALME.3M; Malme3M; MALME3M; Malme-3 Monolayer | 13.0 | nM | GI50 | C3224 | |
TKC112576 | SK-MEL-5 | SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel | 15.0 | nM | GI50 | C3510 | |
TKC112576 | K562 | K562; K.562; K 562; KO; GM05372; GM05372E | 16.0 | nM | GI50 | C9110 | Orphanet_521 |
TKC112576 | A498 | A498 | 18.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC112576 | OVCAR-3 | Ovcar-3; OVCAR 3; OVCAR.3; NIH:OVCAR-3; NIH:Ovcar-3; NIH:OVCAR3; NIH-OVCAR-3; NIHOVCAR3; OVCAR3; Ovcar3 | 13.0 | nM | GI50 | C105555 | |
TKC112576 | MOLT-4 | Molt-4; MOLT 4; Molt 4; MOLT.4; MOLT4; Molt4; GM02219; GM02219C; GM2219C; GM02219D | 12.0 | nM | GI50 | C9142 | Orphanet_99861 |
TKC112576 | HOP-62 | HOP 62; Hop 62; HOP.62; HOP62; Hop62; Hopkins-62 | 11.0 | nM | GI50 | C3512 | |
TKC112576 | NCI/ADR-RES | NCI/ADR-RES; NCI.ADR.RES; NCIADR.RES; NCI/ADRRES; NCIADRRES; ADR-RES; MCF-7/ADR; MCF-7/ADR-RES; MCF-7/AdrR; MCF-7/Adr; MCF-7/adr; MCF-7ADR; MCF7-ADR; MCF7ADR; OVCAR-8/ADR; OVCAR8/ADR | 12.0 | nM | GI50 | C105555 | |
TKC112576 | U-251 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) | 22.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC112576 | OVCAR-5 | OVCAR 5; NIH:OVCAR-5; OVCAR.5; OVCAR5; Ovcar5; OVCA5 | 15.0 | nM | GI50 | C105555 | |
TKC112576 | OVCAR-8 | OVCAR 8; NIH:OVCAR-8; OVCAR8; Ovcar8; OVCAR.8; OVCA8 | 20.0 | nM | GI50 | C105555 | |
TKC112576 | SNB-19 | SNB.19; SNB19; Surgical Neurology Branch-19 | 30.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC112576 | MDA-MB-231 | MDA_MB_231; MDA-MB 231; MDA.MB.231; MDA MB 231; MDA MB231; MDA Mb231; MDA-MB231; MDAMB-231; MDAMB231; MDA-231; MDA-231P; MDA231; MDA231-BRE; MB231; MD Anderson-Metastatic Breast-231 | 129.0 | nM | GI50 | C5214 | |
TKC112576 | SR | SR-786; SR786 | 15.0 | nM | GI50 | C37193 | Orphanet_300895 |
TKC112576 | TK-10 | TK.10; TK 10; TK10 | 11.0 | nM | GI50 | C4033 | Orphanet_319276 |
TKC112576 | SW-620 | SW-620; SW 620; SW.620 | 20.0 | nM | GI50 | C4349 | |
TKC112576 | NCI-H522 | NCI.H522; H522; H-522; NCI-522; NCI522; NCIH522 | 15.0 | nM | GI50 | C3512 | |
TKC112576 | KM12 | KM-12; KM.12 | 34.0 | nM | GI50 | C4910 | |
TKC112576 | M14 | M14-MEL; UCLA-SO-M14; UCLA SO M14; UCLA-SO-14; UCLASO-M14; Melanoma 14; M-14 | 21.0 | nM | GI50 | C3802 | |
TKC112576 | NCI-H322M | NCI.H322M; H322M; H-322M; H-322m | 13.0 | nM | GI50 | C2923 | |
TKC112576 | RPMI-8226 | RPMI 8226; RPMI.8226; RPMI8226; RPMI no. 8226; RPMI no 8226; RPMI #8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; GM02132C; Simpson | 17.0 | nM | GI50 | C3242 | Orphanet_29073 |
TKC112576 | OVCAR-4 | OVCAR 4; NIH:OVCAR-4; NIH:OVCAR4; OVCAR.4; OVCAR4; Ovcar4 | 12.0 | nM | GI50 | C105555 | |
TKC112576 | LOX IMVI | LOX/IMVI; LOX IMVI; LOXIM-VI; LOXIMVI; LOX | 20.0 | nM | GI50 | C3802 | |
TKC112576 | BT-549 | BT 549; BT.549; BT549 | 13.0 | nM | GI50 | C4194 | |
TKC112576 | SK-MEL-2 | SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2 | 19.0 | nM | GI50 | C3224 | |
TKC112576 | A549 | 27.0 | nM | IC50 | C3512 | ||
TKC112576 | HCC 2998 | HCC-2998; HCC.2998; HCC 2998; Hamon Cancer Center 2998 | 61.0 | nM | GI50 | C4349 | |
TKC112576 | SNB-75 | SNB.75; SNB75; Surgical Neurology Branch-75 | 16.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC112576 | HCT-15 | HCT-15; HCT.15; HCT15 | 13.0 | nM | GI50 | C4349 | |
TKC112576 | SF-268 | SF-268; SF.268; SF 268 | 14.0 | nM | GI50 | C60781 | Orphanet_94 |
TKC112576 | MCF7 | 133.0 | nM | IC50 | C4194 | ||
TKC112576 | EKVX | 11.0 | nM | GI50 | C3512 | ||
TKC112576 | PC-3 | PC3; PC.3 | 43.0 | nM | IC50 | C4863 | |
TKC112576 | SK-OV-3 | SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3 | 16.0 | nM | GI50 | C7978 | |
TKC112576 | NCI-H460 | NCI.H460; H460; H-460; NCIH460; NCI-HUT-460; NCI-460 | 11.0 | nM | GI50 | C4450 | |
TKC112576 | T47D | 385.0 | nM | IC50 | C4194 | ||
TKC112576 | UACC-62 | UACC 62; UACC.62; UACC62; University of Arizona Cell Culture-62 | 38.0 | nM | GI50 | C3224 | |
TKC112576 | CAKI-1 | CAL 1; Centre Antoine Lacassagne-1 | 15.0 | nM | GI50 | C3224 | |
TKC112576 | MDA-MB-435 | MDA-MB435; MDAMB435; MDA.MB.435; MDA-435; MDA 435; MDA435; MD Anderson-Metastatic Breast-435 | 22.0 | nM | GI50 | C3802 | |
TKC112576 | SF-295 | SF-295; SF.295; SF 295 | 14.0 | nM | GI50 | C3058 | Orphanet_360 |
TKC112576 | IGROV-1 | Igrov-1; IGROV 1; IGR-OV1; IGROV1; Igrov1; IGR.OV1; IGROV; OV1/P; OV1/p; OV1-P | 16.0 | nM | GI50 | C7979 | Orphanet_454723 |
TKC112576 | Hs-578T | HS 578T; Hs-578T; HS-578T; Hs_578t; Hs-578-T; HS-578-T; Hs 578.T; HS578T; Hs578T; Hs578t; HS0578T; 578T; HS578; Hs578; Homo sapiens No. 578, tumor cells | 93000.0 | nM | IC50 | C4194 | |
TKC112576 | 786-0 | 786-o; 786O; 786-0; 786.O; 786-O RCC; RCC 786-O; RCC_7860; RCC 7860; 7860; 786-0WT | 13.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC112576 | UACC-257 | UACC 257; UACC.257; UACC257; University of Arizona Cell Culture-257 | 24.0 | nM | GI50 | C3224 | |
TKC112576 | CCRF-CEM | CCRF/CEM; CCRFCEM; CCRF.CEM; CCRF CEM; CCRF; CEM; CEM-CCRF; CEM-CCRF (CAMR); CCRF/CEM/0; CEM/0; CEM-0; CCRF-CEM/S; GM03671; GM03671C | 21086.0 | nM | GI50 | C7953 | Orphanet_99861 |
TKC112576 | NCI-H226 | NCI.H226; NCI H226; H226; H-226; HUT-226; HUT 226; NCIH226 | 17.0 | nM | GI50 | C45662 | Orphanet_50251 |
TKC112576 | SK-MEL-28 | SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36 | 211.0 | nM | IC50 | C3510 | |
TKC112576 | RXF 393 | RXF393L; RXF-393 L; RXF-393; RXF 393; RXF.393; RXF393; RXF 393NL | 13.0 | nM | GI50 | C9385 | Orphanet_217071 |
TKC112576 | COLO 205 | Colo 205; CoLo 205; COLO-205; Colo-205; COLO.205; Colo205; COLO205; Co 205; Colorado 205 | 27.0 | nM | GI50 | C4349 | |
TKC112576 | SK-BR-3 | SK-Br-3; Sk-Br-3; SK BR 03; SKBR-3; SKBr-3; SK-BR3; SKBr3; SkBr3; SKBR3 | 403.0 | nM | IC50 | C5214 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC112576 | Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH2 | 5800 | nM | IC50 |
TKC112576 | Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH2 | 5800 | nM | IC50 |
TKC112576 | Q16637 | Survival motor neuron protein | SMN1,SMN2 | 100 | nM | Potency |
TKC112576 | Q16637 | Survival motor neuron protein | SMN1,SMN2 | 100 | nM | Potency |
TKC112576 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 237 | nM | Potency |
TKC112576 | Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | SLCO1B3 | 98 | % | Inhibition |
TKC112576 | Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | SLCO1B1 | 51 | % | Inhibition |
TKC112576 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | IDH1 | 130 | nM | Potency |
TKC112576 | P84022 | Mothers against decapentaplegic homolog 3 | SMAD3 | 206 | nM | Potency |
TKC112576 | Q16236 | Nuclear factor erythroid 2-related factor 2 | NFE2L2 | 33 | nM | Potency |
TKC112576 | Q99700 | Ataxin-2 | ATXN2 | 8 | nM | Potency |
TKC112576 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 1413 | nM | Potency |
TKC112576 | O75496 | Geminin | GMNN | 92 | nM | Potency |
TKC112576 | O89049 | Thioredoxin reductase 1, cytoplasmic | Txnrd1 | 37686 | nM | Potency |
TKC112576 | P40763 | Signal transducer and activator of transcription 3 | STAT3 | 1154 | nM | IC50 |
TKC112576 | O42275 | Acetylcholinesterase | ache | -4 | % | Inhibition |
TKC112576 | P0DTD1 | Replicase polyprotein 1ab | rep | <97 | nM | IC50 |
TKC112576 | P81908 | Cholinesterase | BCHE | 5 | % | Inhibition |
TKC112576 | Q9WKE8 | Reverse transcriptase | reverse transcriptase | >200 | ug.mL-1 | IC50 |
TKC112576 | P00811 | Beta-lactamase | ampC | 25119 | nM | Potency |
TKC112576 | Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | EHMT2 | 10000 | nM | Potency |
TKC112576 | Q96QE3 | ATPase family AAA domain-containing protein 5 | ATAD5 | 65 | nM | Potency |
TKC112576 | P63096 | Guanine nucleotide-binding protein G | GNAI1 | 4467 | nM | Potency |
TKC112576 | Q01453 | Peripheral myelin protein 22 | PMP22 | 84921 | nM | Potency |
TKC112576 | P02791 | Ferritin light chain | FTL | 44668 | nM | Potency |
TKC112576 | P05023 | Sodium/potassium-transporting ATPase subunit alpha-1 | ATP1A1 | 6000 | nM | IC50 |
TKC112576 | P05023 | Sodium/potassium-transporting ATPase subunit alpha-1 | ATP1A1 | 97 | nM | Ki |
TKC112576 | P02545 | Prelamin-A/C | LMNA | 32 | nM | Potency |
TKC112576 | O15118 | NPC intracellular cholesterol transporter 1 | NPC1 | 159 | nM | Potency |
TKC112576 | P51151 | Ras-related protein Rab-9A | RAB9A | 126 | nM | Potency |
TKC112576 | P04637 | Cellular tumor antigen p53 | TP53 | 50 | nM | Potency |
TKC112576 | O94956 | Solute carrier organic anion transporter family member 2B1 | SLCO2B1 | -24 | % | Inhibition |
TKC112576 | O95342 | Bile salt export pump | ABCB11 | >1000000 | nM | IC50 |
TKC112576 | P54707 | Potassium-transporting ATPase alpha chain 2 | ATP12A | 200000 | nM | IC50 |
TKC112576 | P42224 | Signal transducer and activator of transcription 1-alpha/beta | STAT1 | >55700 | nM | IC50 |
TKC112576 | P46720 | Solute carrier organic anion transporter family member 1A1 | Slco1a1 | 52 | % | Activity |
TKC112576 | O35913 | Solute carrier organic anion transporter family member 1A4 | Slco1a4 | 470000 | nM | Km |
TKC112576 | O88397 | Solute carrier organic anion transporter family member 1A5 | Slco1a5 | 1571000 | nM | Km |
TKC112576 | P46721 | Solute carrier organic anion transporter family member 1A2 | SLCO1A2 | 5500000 | nM | Km |
TKC112576 | P06686 | Sodium/potassium-transporting ATPase subunit alpha-2 | Atp1a2 | 170 | nM | IC50 |
TKC112576 | Q6ZQN7 | Solute carrier organic anion transporter family member 4C1 | SLCO4C1 | 380 | nM | Km |
TKC112576 | P50993 | Sodium/potassium-transporting ATPase subunit alpha-2 | ATP1A2 | 90 | nM | Ki |
TKC112576 | Q64541 | Sodium/potassium-transporting ATPase subunit alpha-4 | Atp1a4 | 4 | nM | IC50 |
TKC112576 | Q64541 | Sodium/potassium-transporting ATPase subunit alpha-4 | Atp1a4 | 4.3 | nM | IC50 |
TKC112576 | P06685 | Sodium/potassium-transporting ATPase subunit alpha-1 | Atp1a1 | 4300 | nM | IC50 |
TKC112576 | P06685 | Sodium/potassium-transporting ATPase subunit alpha-1 | Atp1a1 | 4300 | nM | IC50 |
TKC112576 | P06687 | Sodium/potassium-transporting ATPase subunit alpha-3 | Atp1a3 | 31 | nM | IC50 |
TKC112576 | Q13887 | Krueppel-like factor 5 | KLF5 | 165 | nM | IC50 |
TKC112576 | Q63377 | Sodium/potassium-transporting ATPase subunit beta-3 | Atp1b3 | 2 | nM | IC50 |
TKC112576 | P07340 | Sodium/potassium-transporting ATPase subunit beta-1 | Atp1b1 | 3.1 | nM | IC50 |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
Q12809 | KCNH2_HUMAN | Heart failure [ICD-11: BD10-BD1Z] |
Q12809 | KCNH2_HUMAN | Sleep-wake disorder [ICD-11: 7A00-7B2Z] |
Q12809 | KCNH2_HUMAN | Malaria [ICD-11: 1F40-1F45] |
Q12809 | KCNH2_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
Q12809 | KCNH2_HUMAN | Pain [ICD-11: MG30-MG3Z] |
Q12809 | KCNH2_HUMAN | Cardiac arrhythmia [ICD-11: BC9Z] |
Q12809 | KCNH2_HUMAN | Angina pectoris [ICD-11: BA40] |
Q12809 | KCNH2_HUMAN | Genetic cardiac arrhythmia [ICD-11: BC65] |
Q12809 | KCNH2_HUMAN | Ovarian cancer [ICD-11: 2C73] |
Q12809 | KCNH2_HUMAN | Heart failure [ICD-11: BD10-BD1Z] |
Q12809 | KCNH2_HUMAN | Sleep-wake disorder [ICD-11: 7A00-7B2Z] |
Q12809 | KCNH2_HUMAN | Malaria [ICD-11: 1F40-1F45] |
Q12809 | KCNH2_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
Q12809 | KCNH2_HUMAN | Pain [ICD-11: MG30-MG3Z] |
Q12809 | KCNH2_HUMAN | Cardiac arrhythmia [ICD-11: BC9Z] |
Q12809 | KCNH2_HUMAN | Angina pectoris [ICD-11: BA40] |
Q12809 | KCNH2_HUMAN | Genetic cardiac arrhythmia [ICD-11: BC65] |
Q12809 | KCNH2_HUMAN | Ovarian cancer [ICD-11: 2C73] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
Q16637 | SMN_HUMAN | Muscular atrophy [ICD-11: 8B61] |
O75874 | IDHC_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 | IDHC_HUMAN | Liver cancer [ICD-11: 2C12] |
O75874 | IDHC_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O75874 | IDHC_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75874 | IDHC_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 | IDHC_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P84022 | SMAD3_HUMAN | Herpes simplex infection [ICD-11: 1F00] |
P84022 | SMAD3_HUMAN | Kidney fibrosis [ICD-11: GC01] |
Q16236 | NF2L2_HUMAN | Ataxic disorder [ICD-11: 8A03] |
Q16236 | NF2L2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 | NF2L2_HUMAN | Glaucoma [ICD-11: 9C61] |
Q16236 | NF2L2_HUMAN | Lung cancer [ICD-11: 2C25] |
Q16236 | NF2L2_HUMAN | Macular degeneration [ICD-11: 9B75] |
Q16236 | NF2L2_HUMAN | Melanoma [ICD-11: 2C30] |
Q16236 | NF2L2_HUMAN | Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 | NF2L2_HUMAN | Pulmonary hypertension [ICD-11: BB01] |
Q16236 | NF2L2_HUMAN | Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 | NF2L2_HUMAN | Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 | NF2L2_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 | NF2L2_HUMAN | Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 | NF2L2_HUMAN | Motor neuron disease [ICD-11: 8B60] |
Q16236 | NF2L2_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
P27695 | APEX1_HUMAN | Retinopathy [ICD-11: 9B71] |
P27695 | APEX1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Ocular cancer [ICD-11: 2D00-2D07] |
P27695 | APEX1_HUMAN | Brain cancer [ICD-11: 2A00] |
P27695 | APEX1_HUMAN | Melanoma [ICD-11: 2C30] |
P40763 | STAT3_HUMAN | Psoriasis [ICD-11: EA90] |
P40763 | STAT3_HUMAN | Brain cancer [ICD-11: 2A00] |
P40763 | STAT3_HUMAN | Colorectal cancer [ICD-11: 2B91] |
P40763 | STAT3_HUMAN | Liver cancer [ICD-11: 2C12] |
P40763 | STAT3_HUMAN | Malignant digestive organ neoplasm [ICD-11: 2C11] |
P40763 | STAT3_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P40763 | STAT3_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P40763 | STAT3_HUMAN | Respiratory infection [ICD-11: CA07-CA4Z] |
P40763 | STAT3_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P40763 | STAT3_HUMAN | Immune system disease [ICD-11: 4A01-4B41] |
P40763 | STAT3_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
P40763 | STAT3_HUMAN | Mature B-cell leukaemia [ICD-11: 2A82] |
P40763 | STAT3_HUMAN | Multiple myeloma [ICD-11: 2A83] |
P40763 | STAT3_HUMAN | Mycosis fungoides [ICD-11: 2B01] |
P40763 | STAT3_HUMAN | Ulcerative colitis [ICD-11: DD71] |
P40763 | STAT3_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q96KQ7 | EHMT2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q96KQ7 | EHMT2_HUMAN | Postoperative inflammation [ICD-11: 1A00-CA43] |
Q96KQ7 | EHMT2_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05023 | AT1A1_HUMAN | Cardiac arrhythmia [ICD-11: BC9Z] |
P05023 | AT1A1_HUMAN | Chronic obstructive pulmonary disease [ICD-11: CA22] |
P05023 | AT1A1_HUMAN | Corneal disease [ICD-11: 9A76-9A78] |
P05023 | AT1A1_HUMAN | Heart failure [ICD-11: BD10-BD1Z] |
P05023 | AT1A1_HUMAN | Hyperhidrosis [ICD-11: EE00] |
P05023 | AT1A1_HUMAN | Malaria [ICD-11: 1F40-1F45] |
P05023 | AT1A1_HUMAN | Supraventricular tachyarrhythmia [ICD-11: BC81] |
P05023 | AT1A1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05023 | AT1A1_HUMAN | Cardiac arrhythmia [ICD-11: BC9Z] |
P05023 | AT1A1_HUMAN | Chronic obstructive pulmonary disease [ICD-11: CA22] |
P05023 | AT1A1_HUMAN | Corneal disease [ICD-11: 9A76-9A78] |
P05023 | AT1A1_HUMAN | Heart failure [ICD-11: BD10-BD1Z] |
P05023 | AT1A1_HUMAN | Hyperhidrosis [ICD-11: EE00] |
P05023 | AT1A1_HUMAN | Malaria [ICD-11: 1F40-1F45] |
P05023 | AT1A1_HUMAN | Supraventricular tachyarrhythmia [ICD-11: BC81] |
P05023 | AT1A1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P51151 | RAB9A_HUMAN | Fungal infection [ICD-11: 1F29-1F2F] |
P04637 | P53_HUMAN | Arterial occlusive disease [ICD-11: BD40] |
P04637 | P53_HUMAN | Lip/oral cavity/pharynx neoplasm [ICD-11: 2B6E] |
P04637 | P53_HUMAN | Metastatic liver/bile duct neoplasm [ICD-11: 2D80] |
P04637 | P53_HUMAN | Transplant rejection [ICD-11: NE84] |
P04637 | P53_HUMAN | Ovarian dysfunction [ICD-11: 5A80] |
P04637 | P53_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P04637 | P53_HUMAN | Bladder cancer [ICD-11: 2C94] |
P04637 | P53_HUMAN | Brain cancer [ICD-11: 2A00] |
P04637 | P53_HUMAN | Colorectal cancer [ICD-11: 2B91] |
P04637 | P53_HUMAN | Esophageal cancer [ICD-11: 2B70] |
P04637 | P53_HUMAN | Head and neck cancer [ICD-11: 2D42] |
P04637 | P53_HUMAN | Mature B-cell leukaemia [ICD-11: 2A82] |
P04637 | P53_HUMAN | Myelodysplastic syndrome [ICD-11: 2A37] |
P04637 | P53_HUMAN | Ovarian cancer [ICD-11: 2C73] |
P04637 | P53_HUMAN | Pancreatic cancer [ICD-11: 2C10] |
P04637 | P53_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04637 | P53_HUMAN | Stomach cancer [ICD-11: 2B72] |
P04637 | P53_HUMAN | Cervical cancer [ICD-11: 2C77] |
P04637 | P53_HUMAN | Endometrial cancer [ICD-11: 2C76] |
P04637 | P53_HUMAN | Fallopian tube cancer [ICD-11: 2C74] |
P04637 | P53_HUMAN | Liposarcoma [ICD-11: 2B59] |
P04637 | P53_HUMAN | Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P04637 | P53_HUMAN | Peritoneal cancer [ICD-11: 2C51] |
P04637 | P53_HUMAN | Toxicity [ICD-11: N.A.] |
P04637 | P53_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P04637 | P53_HUMAN | Acute myeloid leukaemia [ICD-11: 2A60] |
P04637 | P53_HUMAN | Kidney failure [ICD-11: GB60-GB6Z] |
P04637 | P53_HUMAN | Hearing disorder [ICD-11: AB50-AB57] |
P42224 | STAT1_HUMAN | Skin and skin-structure infection [ICD-11: 1F28-1G0Z] |
Q6ZQN7 | SO4C1_HUMAN | Cardiac arrhythmia [ICD-11: BC9Z] |
Q6ZQN7 | SO4C1_HUMAN | Heart failure [ICD-11: BD10-BD1Z] |